CN111701001A - Medicine for treating gallstones and kidney stones - Google Patents
Medicine for treating gallstones and kidney stones Download PDFInfo
- Publication number
- CN111701001A CN111701001A CN202010765444.XA CN202010765444A CN111701001A CN 111701001 A CN111701001 A CN 111701001A CN 202010765444 A CN202010765444 A CN 202010765444A CN 111701001 A CN111701001 A CN 111701001A
- Authority
- CN
- China
- Prior art keywords
- parts
- raw
- medicine
- gallstones
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Marine Sciences & Fisheries (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to the technical field of traditional Chinese medicines, in particular to a medicine for treating gallstones and kidney stones. The medicine for treating the gallstones and the kidney stones comprises the following components in parts by weight: 0.5-1 part of asteriscus Pseudosciaenae; 0.5-1 part of autumn stone; 1-3 parts of raw rhubarb; 1-3 parts of cudrania cochinchinensis; 1-3 parts of pyrrosia lingua; 1-3 parts of lygodium japonicum; 1-3 parts of talc; 1-3 parts of pumice; 1-3 parts of rhizoma sparganii; 1-3 parts of curcuma zedoary; 2-4 parts of raw gizzard pepsin; 2-4 parts of raw astragalus; 5-7 parts of desmodium. The medicine for treating the gallstones and the kidney stones, provided by the invention, has reasonable compatibility, accords with the principle of 'monarch, minister, assistant and guide' and accords with the pathogenesis of gallstones, kidney stones and bladder stones; has effects of promoting bile flow, removing calculus, removing toxic substance, relieving inflammation, activating qi-flowing, and resolving stagnation, and is suitable for patients with various cholelithiasis, nephrolithiasis, and vesical calculus.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to a medicine for treating gallstones and kidney stones.
Background
Gallstones are common diseases of biliary systems, and the incidence rate of gallstones in China can reach 7-12% with the age, which is common in clinic. Gallstone diseases are complicated in cause and pathogenesis, and the gallstones are divided into peribiliary involutes 37241, cholechromic stones, uric acid stones, oxalic acid stones, gallstones, extravasated blood stones, sputum nucleus stones, gallbladder obstruction stones, gallbladder stagnation stones, metabolic stones, sandstone stones and the like in traditional Chinese medicine.
The stimulation of factors such as diet disorder, cold and warm discomfort, emotional injury and the like can cause the liver and gallbladder of a person to lose regulation and catharsis, so that damp-heat is generated in the body and the qi activity is not smooth; decocting bile into stone for a long time; the further development of cholelithiasis due to retention of damp-heat may cause toxic heat in the body, yellow skin by toxic heat or fumigation, or deep-seated nutrient-blood syncope, causing systemic critical symptoms.
The occurrence of gallstones is related to factors such as individual differences, self-response, medication, disease, environment, diet of patients, and the like. The treatment of gallstones is also carried out according to specific causes, so that the best treatment effect can be achieved.
The common treatment for gallstones is lithotripsy, but the cause of the gallstones is not removed by the treatment, so that the recurrence of the gallstones is not surprising. The combination of surgery and calculus can cause the problem of incomplete removal of calculus, and the diet remained in the body is also the main reason of relapse. Gradually grow larger over time, resulting in relapse. The invention explains and treats gallstones, kidney stones and bladder stones from the perspective of traditional Chinese medicine, so as to reduce pain of stone patients.
Disclosure of Invention
Aiming at the defects in the prior art, the invention provides a medicine for treating the gallstones and the kidney stones, solves the technical problems and provides a medicine for treating the gallstones and the kidney stones.
In order to achieve the purpose, the invention provides the following technical scheme:
the medicine for treating the gallstones and the kidney stones comprises the following components in parts by weight: 0.5-1.5 parts of asteriscus Pseudosciaenae; 0.5-1.5 parts of autumn stone; 1-3 parts of raw rhubarb; 1-3 parts of cudrania cochinchinensis; 1-3 parts of pyrrosia lingua; 1-3 parts of lygodium japonicum; 1-3 parts of talc; 1-3 parts of pumice; 1-3 parts of rhizoma sparganii; 1-3 parts of curcuma zedoary; 2-4 parts of raw gizzard pepsin; 2-4 parts of raw astragalus; 5-7 parts of desmodium.
The medicine for treating the gallstones and the kidney stones comprises the following components in parts by weight: 1 part of asteriscus Pseudosciaenae; 1 part of autumn stone; 2 parts of raw rhubarb; 2 parts of a cudrania root; 2 parts of pyrrosia lingua; 2 parts of lygodium japonicum; 2 parts of talc; 2 parts of pumice; 2 parts of rhizoma sparganii; 2 parts of curcuma zedoary; 3 parts of raw gizzard pepsin; 3 parts of raw astragalus; 6 parts of desmodium.
The medicine for treating the gallstones and the kidney stones comprises the following components in parts by weight: 0.5 part of asteriscus Pseudosciaenae; 0.5 part of autumn stone; 1 part of raw rhubarb; 1 part of cudrania cochinchinensis; 1 part of pyrrosia lingua; 1 part of spora lygodii; 1 part of talc; 1 part of pumice; 3 parts of rhizoma sparganii; 3 parts of curcuma zedoary; 2 parts of raw gizzard pepsin; 2 parts of raw astragalus; 5 parts of desmodium.
The medicine for treating the gallstones and the kidney stones comprises the following components in parts by weight: 1.5 parts of asteriscus Pseudosciaenae; 1.5 parts of autumn stones; 3 parts of raw rhubarb; 3 parts of a cudrania cochinchinensis; 3 parts of pyrrosia lingua; 3 parts of lygodium japonicum; 3 parts of talc; 3 parts of pumice; 1 part of rhizoma sparganii; 1 part of curcuma zedoary; 4 parts of raw gizzard pepsin; 4 parts of raw astragalus; 7 parts of desmodium.
A medicine for treating gallstones and kidney stones comprises the following preparation method:
the method comprises the following steps: decocting the above materials in water in casserole for 30-45min, removing residue, and keeping medicinal liquid;
step two: concentrating the medicinal liquid, and making into concentrated pill, capsule, tablet or granule.
The invention has the beneficial effects that: the medicine for treating the gallstones and the kidney stones, provided by the invention, conforms to the principle of 'monarch, minister, assistant and guide' and conforms to the pathogenesis of gallstones, kidney stones and bladder stones; has effects of promoting bile flow, removing calculus, removing toxic substance, relieving inflammation, activating qi-flowing, and resolving stagnation, and is suitable for patients with various cholelithiasis, nephrolithiasis, and vesical calculus.
For a better understanding of the features and technical content of the present invention, refer to the following detailed description of the invention.
Detailed Description
To further illustrate the technical means adopted by the present invention and the effects thereof, the following detailed description is given with reference to the preferred embodiments of the present invention.
The medicine for treating the gallstones and the kidney stones comprises the following components in parts by weight: 0.5-1.5 parts of asteriscus Pseudosciaenae; 0.5-1.5 parts of autumn stone; 1-3 parts of raw rhubarb; 1-3 parts of cudrania cochinchinensis; 1-3 parts of pyrrosia lingua; 1-3 parts of lygodium japonicum; 1-3 parts of talc; 1-3 parts of pumice; 1-3 parts of rhizoma sparganii; 1-3 parts of curcuma zedoary; 2-4 parts of raw gizzard pepsin; 2-4 parts of raw astragalus; 5-7 parts of desmodium.
Example 1:
the medicine for treating the gallstones and the kidney stones comprises the following components in parts by weight: 1 part of asteriscus Pseudosciaenae; 1 part of autumn stone; 2 parts of raw rhubarb; 2 parts of a cudrania root; 2 parts of pyrrosia lingua; 2 parts of lygodium japonicum; 2 parts of talc; 2 parts of pumice; 2 parts of rhizoma sparganii; 2 parts of curcuma zedoary; 3 parts of raw gizzard pepsin; 3 parts of raw astragalus; 6 parts of desmodium.
A medicine for treating gallstones and kidney stones comprises the following preparation method:
the method comprises the following steps: decocting the above materials in water for 40min, removing residue, and keeping medicinal liquid;
step two: concentrating the medicinal liquid, and making into concentrated pill, capsule, tablet or granule.
Example 2:
the medicine for treating the gallstones and the kidney stones comprises the following components in parts by weight: 0.5 part of asteriscus Pseudosciaenae; 0.5 part of autumn stone; 1 part of raw rhubarb; 1 part of cudrania cochinchinensis; 1 part of pyrrosia lingua; 1 part of spora lygodii; 1 part of talc; 1 part of pumice; 3 parts of rhizoma sparganii; 3 parts of curcuma zedoary; 2 parts of raw gizzard pepsin; 2 parts of raw astragalus; 5 parts of desmodium.
A medicine for treating gallstones and kidney stones comprises the following preparation method:
the method comprises the following steps: decocting the above materials in water for 30min, removing residue, and keeping medicinal liquid;
step two: concentrating the medicinal liquid, and making into concentrated pill, capsule, tablet or granule.
Example 3:
the medicine for treating the gallstones and the kidney stones comprises the following components in parts by weight: 1.5 parts of asteriscus Pseudosciaenae; 1.5 parts of autumn stones; 3 parts of raw rhubarb; 3 parts of a cudrania cochinchinensis; 3 parts of pyrrosia lingua; 3 parts of lygodium japonicum; 3 parts of talc; 3 parts of pumice; 1 part of rhizoma sparganii; 1 part of curcuma zedoary; 4 parts of raw gizzard pepsin; 4 parts of raw astragalus; 7 parts of desmodium.
A medicine for treating gallstones and kidney stones comprises the following preparation method:
the method comprises the following steps: decocting the above materials in water for 45min, removing residue, and keeping medicinal liquid;
step two: concentrating the medicinal liquid, and making into concentrated pill, capsule, tablet or granule.
Typical cases are as follows:
xia Dou, woman, 60 years old, Beijing. The patient feels discomfort in the stomach in 2015, often relieves qi, is warm and painful, is painful in the waist, is suddenly aggravated in 2015 in 8 months, vomits, then goes to a hospital for B-ultrasonic examination, and is cholecystitis, 2 pieces of gallstone with the size of 28mm multiplied by 13mm and 12mm multiplied by 6mm, the concentrated pill prepared in the embodiment 1 of the invention is used for two treatment courses, each treatment course is 15 days, three times a day, is taken with cold boiled water, and is subjected to B-ultrasonic examination in county hospitals after one month, the cholecystitis is cured, and the gallstone disappears.
Zhang somean, woman, age 30, Shandong. The medicinal granules prepared in the embodiment 2 of the invention are taken for 4 courses of treatment, wherein the granules are used for 2015 patients with gastropathy, cholecystitis is caused by B-ultrasonic examination in a hospital, and gallstone is 23mm multiplied by 14 mm; the medicine is taken for 2 courses of treatment after the gallbladder calculus is filled in the hospital for rechecking, and the calculus is disappeared and healed after rechecking again.
100 patients suffering from the cholelithiasis and the renal calculus treatment drug of the embodiment 1 in the invention is used, and the effective rate is 96% after 1 month of treatment.
The above description is only for the specific embodiments of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art can easily conceive of the changes or substitutions within the technical scope of the present invention, and all the changes or substitutions should be covered within the scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the protection scope of the claims.
Claims (5)
1. The medicine for treating the gallstones and the kidney stones is characterized by comprising the following components in parts by weight: 0.5-1.5 parts of asteriscus Pseudosciaenae; 0.5-1.5 parts of autumn stone; 1-3 parts of raw rhubarb; 1-3 parts of cudrania cochinchinensis; 1-3 parts of pyrrosia lingua; 1-3 parts of lygodium japonicum; 1-3 parts of talc; 1-3 parts of pumice; 1-3 parts of rhizoma sparganii; 1-3 parts of curcuma zedoary; 2-4 parts of raw gizzard pepsin; 2-4 parts of raw astragalus; 5-7 parts of desmodium.
2. The medicine for treating cholelithiasis and nephrolithiasis as claimed in claim 1, which is characterized by comprising the following components in parts by weight: 1 part of asteriscus Pseudosciaenae; 1 part of autumn stone; 2 parts of raw rhubarb; 2 parts of a cudrania root; 2 parts of pyrrosia lingua; 2 parts of lygodium japonicum; 2 parts of talc; 2 parts of pumice; 2 parts of rhizoma sparganii; 2 parts of curcuma zedoary; 3 parts of raw gizzard pepsin; 3 parts of raw astragalus; 6 parts of desmodium.
3. The medicine for treating cholelithiasis and nephrolithiasis as claimed in claim 1, which is characterized by comprising the following components in parts by weight: 0.5 part of asteriscus Pseudosciaenae; 0.5 part of autumn stone; 1 part of raw rhubarb; 1 part of cudrania cochinchinensis; 1 part of pyrrosia lingua; 1 part of spora lygodii; 1 part of talc; 1 part of pumice; 3 parts of rhizoma sparganii; 3 parts of curcuma zedoary; 2 parts of raw gizzard pepsin; 2 parts of raw astragalus; 5 parts of desmodium.
4. The medicine for treating cholelithiasis and nephrolithiasis as claimed in claim 1, which is characterized by comprising the following components in parts by weight: 1.5 parts of asteriscus Pseudosciaenae; 1.5 parts of autumn stones; 3 parts of raw rhubarb; 3 parts of a cudrania cochinchinensis; 3 parts of pyrrosia lingua; 3 parts of lygodium japonicum; 3 parts of talc; 3 parts of pumice; 1 part of rhizoma sparganii; 1 part of curcuma zedoary; 4 parts of raw gizzard pepsin; 4 parts of raw astragalus; 7 parts of desmodium.
5. The medicine for treating cholelithiasis and nephrolithiasis as claimed in claim 1, which is prepared by the following steps:
the method comprises the following steps: decocting the above materials in water in casserole for 30-45min, removing residue, and keeping medicinal liquid;
step two: concentrating the medicinal liquid, and making into concentrated pill, capsule, tablet or granule.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010765444.XA CN111701001A (en) | 2020-07-31 | 2020-07-31 | Medicine for treating gallstones and kidney stones |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010765444.XA CN111701001A (en) | 2020-07-31 | 2020-07-31 | Medicine for treating gallstones and kidney stones |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111701001A true CN111701001A (en) | 2020-09-25 |
Family
ID=72546932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010765444.XA Withdrawn CN111701001A (en) | 2020-07-31 | 2020-07-31 | Medicine for treating gallstones and kidney stones |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111701001A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101700384A (en) * | 2009-11-13 | 2010-05-05 | 黄远吉 | Traditional Chinese medicine composition for treating renal calculus and vesical calculus |
CN102274452A (en) * | 2011-06-03 | 2011-12-14 | 文登市大水泊镇乐园村卫生室 | Traditional Chinese medicine for treating gall-stone |
CN104547879A (en) * | 2013-10-16 | 2015-04-29 | 栾晓明 | Traditional Chinese medicine for treating cholelithiasis |
CN104922583A (en) * | 2014-03-21 | 2015-09-23 | 吴旭 | Traditional Chinese medicine for specially treating gallstone |
CN106039237A (en) * | 2016-07-31 | 2016-10-26 | 黄平县兴且民族民间中草医药科学发展有限责任公司 | Traditional Chinese medicinal formula for treating nephrolithiasis |
CN109288995A (en) * | 2018-11-26 | 2019-02-01 | 董明恒 | A kind of herbal composite and preparation method thereof for treating calculus |
-
2020
- 2020-07-31 CN CN202010765444.XA patent/CN111701001A/en not_active Withdrawn
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101700384A (en) * | 2009-11-13 | 2010-05-05 | 黄远吉 | Traditional Chinese medicine composition for treating renal calculus and vesical calculus |
CN102274452A (en) * | 2011-06-03 | 2011-12-14 | 文登市大水泊镇乐园村卫生室 | Traditional Chinese medicine for treating gall-stone |
CN104547879A (en) * | 2013-10-16 | 2015-04-29 | 栾晓明 | Traditional Chinese medicine for treating cholelithiasis |
CN104922583A (en) * | 2014-03-21 | 2015-09-23 | 吴旭 | Traditional Chinese medicine for specially treating gallstone |
CN106039237A (en) * | 2016-07-31 | 2016-10-26 | 黄平县兴且民族民间中草医药科学发展有限责任公司 | Traditional Chinese medicinal formula for treating nephrolithiasis |
CN109288995A (en) * | 2018-11-26 | 2019-02-01 | 董明恒 | A kind of herbal composite and preparation method thereof for treating calculus |
Non-Patent Citations (1)
Title |
---|
醉青YPS: "治疗体内各种结石", 《个人图书馆HTTP://WWW.360DOC.COM/CONTENT/20/0520/06/33121103_913402949.SHTML》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106729212B (en) | Compound traditional Chinese medicine composition for treating acute stage of gout and application thereof | |
CN103316315A (en) | Cooling paste | |
CN101983644A (en) | Medicament for treating sequelae of apoplexy | |
CN100350921C (en) | Dermatosis eliminating medicine | |
CN111701001A (en) | Medicine for treating gallstones and kidney stones | |
CN108245602A (en) | It is a kind of to treat dermopathic external medicine composition | |
CN101596263A (en) | A kind of medicine for the treatment of fracture and preparation method thereof | |
CN105147877A (en) | Drug for treating paronychia | |
CN103893436B (en) | A kind of externally applied drug for treating rheumatism | |
CN110787237B (en) | Traditional Chinese medicine composition for effectively treating gastrocnemius spasm and preparation method and application thereof | |
CN101698074A (en) | Medicine for treating soft tissue pain and preparation method thereof | |
CN114392331A (en) | Preparation containing Agkistrodon for treating gouty arthritis | |
CN109260297B (en) | A Chinese medicinal composition for treating hemorrhoid, and its preparation method | |
CN105770339A (en) | Medicament for treating acnes | |
CN104997930A (en) | Muscle and bone plaster | |
CN104491327A (en) | Spraying agent for treating bedsore | |
CN105434734A (en) | Formula and use method of traditional Chinese medicine for treating gallbladder polyps | |
CN104491799B (en) | A kind of traditional Chinese powder medicine for application treatment rheumatoid arthritis | |
CN104189336A (en) | Medicine composition for treating osteoproliferation | |
CN115429834A (en) | A Chinese medicinal compound preparation for treating gout and hyperuricemia, and its preparation method | |
CN104524017A (en) | Traditional Chinese medicine preparation for treating angiitis | |
CN100374144C (en) | Chinese medicinal oral liquid for treating appendicitis and enteritis | |
CN103623091B (en) | Medicament for external use for treating gout | |
CN115554345A (en) | A Chinese medicinal compound preparation for treating gout and hyperuricemia, and its preparation method | |
CN117159642A (en) | Pill for nourishing yin and relaxing bowels |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20200925 |